Global Organ Transplant Rejection Medication Market Size study & Forecast, by Drug Class, by Transplant Type, by Distribution Channel, and Regional Analysis, 2023-2030

Description

List of Tables

Global Organ Transplant Rejection Medication Market is valued at approximately USD 4.9 billion in 2022 and is anticipated to grow with a growth rate of more than 3.9% over the forecast period 2023-2030. Organ transplantation is a surgical procedure in which tissue, or an organ is transferred from one person's body to another person's body. Organ transplant rejection medication is used to prevent organ rejection in transplant recipients. The rising incidence of chronic disease and the increased incidence of organ failure are the key factors responsible for the market growth of the Organ Transplant Rejection Medication Market over the forecast period.

According to the Health Resources and Services Administration. In 2022, in the U.S., more than 42,887 organ transplants were performed and it's an increase of 3.7% over 2021. Also, according to the Department of Health & Human Services, in Mar 2023, approximately 104,234 patients across the globe were waiting to receive organs for transplant. Thus, the rising incidence of chronic disease and the increased incidence of organ failure are fueling the market demand across the globe. Also, advancements in technology, such as new surgical techniques and immunosuppressive drugs and a rise in the number of organ donors accelerate market growth. Moreover, increased awareness about the benefits of organ transplantation in an aging population and an increase in funding for research and development are anticipated to create lucrative growth opportunities for the market. However, the high cost and complex procedures stifle market growth throughout the forecast period of 2023-2030.

The key regions considered for the Global Organ Transplant Rejection Medication Market study includes Asia Pacific, North America, Europe, Latin America, and Middle East & Africa. North America dominated the market in terms of revenue owing to factors such as the rising incidence of chronic disease, favorable reimbursement policies, technological advancement and the presence of advanced healthcare infrastructure create market growth in this region. Asia-Pacific is the fastest-growing region due to increasing incidence of chronic diseases, rising healthcare expenditure, rise in affordability and increased awareness about organ rejection medications in the region.

Major market player included in this report are:

Pfizer, Inc.
Astellas Pharma Global Development, Inc.
F, Hoffmann-La Roche Ltd.
Bristol-Myers Squibb Company
GlaxoSmithKline plc.
AbbVie Inc.
Viatris, Inc.
Hikma Pharmaceuticals plc.
Teva Pharmaceutical Industries Ltd
Cadila Healthcare Limited

Recent Developments in the Market:

In August 2022, Strides gained USFDA certification for their Cyclosporine Softgel Capsule. Strides strengthened its market position by adding Cyclosporine Softgel capsules, Tacrolimus capsules and an immunosuppressive medicine line for the US market.

Global Organ Transplant Rejection Medication Market Report Scope:

Historical Data - 2020 - 2021
Base Year for Estimation - 2022
Forecast period - 2023-2030
Report Coverage - Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered - Drug Class, Transplant Type, Distribution channel, Region
Regional Scope - North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Customization Scope - Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Class:

Antibodies
Antimetabolites
Calcineurin Inhibitors
mTOR Inhibitors
Steroids

By Transplant Type:

Kidney
Liver
Heart
Lung
Pancreas
Others

By Distribution Channel:

Hospitals Pharmacies
Retail Pharmacies
Online Pharmacies

By Region:

North America

U.S.
Canada

Europe

UK
Germany
France
Spain
Italy
ROE

Asia Pacific

China
India
Japan
Australia
South Korea
RoAPAC

Latin America

Brazil
Mexico

Middle East & Africa

Saudi Arabia
South Africa
Rest of Middle East & Africa

Chapter 1. Executive Summary

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2030 (USD Billion)
- 1.2.1. Organ Transplant Rejection Medication Market, by region, 2020-2030 (USD Billion)
- 1.2.2. Organ Transplant Rejection Medication Market, by Drug Class, 2020-2030 (USD Billion)
- 1.2.3. Organ Transplant Rejection Medication Market, by Transplant Type, 2020-2030 (USD Billion)
- 1.2.4. Organ Transplant Rejection Medication Market, by Distribution Channel, 2020-2030 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

Chapter 2. Global Organ Transplant Rejection Medication Market Definition and Scope

2.1. Objective of the Study
2.2. Market Definition & Scope
- 2.2.1. Industry Evolution
- 2.2.2. Scope of the Study
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

Chapter 3. Global Organ Transplant Rejection Medication Market Dynamics

3.1. Organ Transplant Rejection Medication Market Impact Analysis (2020-2030)
- 3.1.1. Market Drivers
  - 3.1.1.1. Rising incidence of chronic disease
  - 3.1.1.2. Increased incidence of organ failure
- 3.1.2. Market Challenges
  - 3.1.2.1. High cost of medication
  - 3.1.2.2. Complex procedures of organ transplant
- 3.1.3. Market Opportunities
  - 3.1.3.1. Increased awareness about the benefits of organ transplantation
  - 3.1.3.2. Increase in funding for research and development

Chapter 4. Global Organ Transplant Rejection Medication Market Industry Analysis

4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
4.2. Porter's 5 Force Impact Analysis
4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economic
- 4.3.3. Social
- 4.3.4. Technological
- 4.3.5. Environmental
- 4.3.6. Legal
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. COVID-19 Impact Analysis
4.7. Disruptive Trends
4.8. Industry Expert Perspective
4.9. Analyst Recommendation & Conclusion

Chapter 5. Global Organ Transplant Rejection Medication Market, by Drug Class

5.1. Market Snapshot
5.2. Global Organ Transplant Rejection Medication Market by Drug Class, Performance - Potential Analysis
5.3. Global Organ Transplant Rejection Medication Market Estimates & Forecasts by Drug Class 2020-2030 (USD Billion)
5.4. Organ Transplant Rejection Medication Market, Sub Segment Analysis
- 5.4.1. Antibodies
- 5.4.2. Antimetabolites
- 5.4.3. Calcineurin Inhibitors
- 5.4.4. mTOR Inhibitors
- 5.4.5. Steroids

Chapter 6. Global Organ Transplant Rejection Medication Market, by Transplant Type

6.1. Market Snapshot
6.2. Global Organ Transplant Rejection Medication Market by Transplant Type, Performance - Potential Analysis
6.3. Global Organ Transplant Rejection Medication Market Estimates & Forecasts by Transplant Type 2020-2030 (USD Billion)
6.4. Organ Transplant Rejection Medication Market, Sub Segment Analysis
- 6.4.1. Kidney
- 6.4.2. Liver
- 6.4.3. Heart
- 6.4.4. Lung
- 6.4.5. Pancreas
- 6.4.6. Others

Chapter 7. Global Organ Transplant Rejection Medication Market, by Distribution Channel

7.1. Market Snapshot
7.2. Global Organ Transplant Rejection Medication Market by Distribution Channel, Performance - Potential Analysis
7.3. Global Organ Transplant Rejection Medication Market Estimates & Forecasts by Distribution Channel 2020-2030 (USD Billion)
7.4. Organ Transplant Rejection Medication Market, Sub Segment Analysis
- 7.4.1. Hospitals Pharmacies
- 7.4.2. Retail Pharmacies
- 7.4.3. Online Pharmacies

Chapter 8. Global Organ Transplant Rejection Medication Market, Regional Analysis

8.1. Top Leading Countries
8.2. Top Emerging Countries
8.3. Organ Transplant Rejection Medication Market, Regional Market Snapshot
8.4. North America Organ Transplant Rejection Medication Market
- 8.4.1. U.S. Organ Transplant Rejection Medication Market
  - 8.4.1.1. Drug Class breakdown estimates & forecasts, 2020-2030
  - 8.4.1.2. Transplant Type breakdown estimates & forecasts, 2020-2030
  - 8.4.1.3. Distribution Channel breakdown estimates & forecasts, 2020-2030
- 8.4.2. Canada Organ Transplant Rejection Medication Market
8.5. Europe Organ Transplant Rejection Medication Market Snapshot
- 8.5.1. U.K. Organ Transplant Rejection Medication Market
- 8.5.2. Germany Organ Transplant Rejection Medication Market
- 8.5.3. France Organ Transplant Rejection Medication Market
- 8.5.4. Spain Organ Transplant Rejection Medication Market
- 8.5.5. Italy Organ Transplant Rejection Medication Market
- 8.5.6. Rest of Europe Organ Transplant Rejection Medication Market
8.6. Asia-Pacific Organ Transplant Rejection Medication Market Snapshot
- 8.6.1. China Organ Transplant Rejection Medication Market
- 8.6.2. India Organ Transplant Rejection Medication Market
- 8.6.3. Japan Organ Transplant Rejection Medication Market
- 8.6.4. Australia Organ Transplant Rejection Medication Market
- 8.6.5. South Korea Organ Transplant Rejection Medication Market
- 8.6.6. Rest of Asia Pacific Organ Transplant Rejection Medication Market
8.7. Latin America Organ Transplant Rejection Medication Market Snapshot
- 8.7.1. Brazil Organ Transplant Rejection Medication Market
- 8.7.2. Mexico Organ Transplant Rejection Medication Market
8.8. Middle East & Africa Organ Transplant Rejection Medication Market
- 8.8.1. Saudi Arabia Organ Transplant Rejection Medication Market
- 8.8.2. South Africa Organ Transplant Rejection Medication Market
- 8.8.3. Rest of Middle East & Africa Organ Transplant Rejection Medication Market

Chapter 9. Competitive Intelligence

9.1. Key Company SWOT Analysis
- 9.1.1. Company 1
- 9.1.2. Company 2
- 9.1.3. Company 3
9.2. Top Market Strategies
9.3. Company Profiles
- 9.3.1. Pfizer, Inc.
  - 9.3.1.1. Key Information
  - 9.3.1.2. Overview
  - 9.3.1.3. Financial (Subject to Data Availability)
  - 9.3.1.4. Product Summary
  - 9.3.1.5. Recent Developments
- 9.3.2. Astellas Pharma Global Development, Inc.
- 9.3.3. F, Hoffmann-La Roche Ltd.
- 9.3.4. Bristol-Myers Squibb Company
- 9.3.5. GlaxoSmithKline plc.
- 9.3.6. AbbVie Inc.
- 9.3.7. Viatris, Inc.
- 9.3.8. Hikma Pharmaceuticals plc.
- 9.3.9. Teva Pharmaceutical Industries Ltd,
- 9.3.10. Cadila Healthcare Limited

Chapter 10. Research Process

10.1. Research Process
- 10.1.1. Data Mining
- 10.1.2. Analysis
- 10.1.3. Market Estimation
- 10.1.4. Validation
- 10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption

LIST OF TABLES

TABLE 1. Global Organ Transplant Rejection Medication Market, report scope
TABLE 2. Global Organ Transplant Rejection Medication Market estimates & forecasts by Region 2020-2030 (USD Billion)
TABLE 3. Global Organ Transplant Rejection Medication Market estimates & forecasts by Drug Class 2020-2030 (USD Billion)
TABLE 4. Global Organ Transplant Rejection Medication Market estimates & forecasts by Transplant Type 2020-2030 (USD Billion)
TABLE 5. Global Organ Transplant Rejection Medication Market estimates & forecasts by Distribution Channel 2020-2030 (USD Billion)
TABLE 6. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 7. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 8. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 9. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 10. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 11. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 12. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 13. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 14. Global Organ Transplant Rejection Medication Market by segment, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 15. Global Organ Transplant Rejection Medication Market by region, estimates & forecasts, 2020-2030 (USD Billion)
TABLE 16. U.S. Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 17. U.S. Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 18. U.S. Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 19. Canada Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 20. Canada Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 21. Canada Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 22. UK Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 23. UK Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 24. UK Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 25. Germany Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 26. Germany Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 27. Germany Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 28. France Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 29. France Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 30. France Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 31. Italy Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 32. Italy Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 33. Italy Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 34. Spain Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 35. Spain Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 36. Spain Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 37. RoE Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 38. RoE Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 39. RoE Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 40. China Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 41. China Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 42. China Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 43. India Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 44. India Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 45. India Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 46. Japan Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 47. Japan Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 48. Japan Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 49. South Korea Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 50. South Korea Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 51. South Korea Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 52. Australia Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 53. Australia Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 54. Australia Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 55. RoAPAC Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 56. RoAPAC Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 57. RoAPAC Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 58. Brazil Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 59. Brazil Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 60. Brazil Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 61. Mexico Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 62. Mexico Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 63. Mexico Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 64. RoLA Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 65. RoLA Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 66. RoLA Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 67. Saudi Arabia Organ Transplant Rejection Medication Market estimates & forecasts, 2020-2030 (USD Billion)
TABLE 68. South Africa Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 69. RoMEA Organ Transplant Rejection Medication Market estimates & forecasts by segment 2020-2030 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Organ Transplant Rejection Medication Market
TABLE 71. List of primary sources, used in the study of global Organ Transplant Rejection Medication Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered

List of tables and figures are dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

FIG 1. Global Organ Transplant Rejection Medication Market, research methodology
FIG 2. Global Organ Transplant Rejection Medication Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Organ Transplant Rejection Medication Market, key trends 2022
FIG 5. Global Organ Transplant Rejection Medication Market, growth prospects 2023-2030
FIG 6. Global Organ Transplant Rejection Medication Market, porters 5 force model
FIG 7. Global Organ Transplant Rejection Medication Market, pest analysis
FIG 8. Global Organ Transplant Rejection Medication Market, value chain analysis
FIG 9. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
FIG 10. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
FIG 11. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
FIG 12. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
FIG 13. Global Organ Transplant Rejection Medication Market by segment, 2020 & 2030 (USD Billion)
FIG 14. Global Organ Transplant Rejection Medication Market, regional snapshot 2020 & 2030
FIG 15. North America Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
FIG 16. Europe Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
FIG 17. Asia pacific Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
FIG 18. Latin America Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)
FIG 19. Middle East & Africa Organ Transplant Rejection Medication Market 2020 & 2030 (USD Billion)